Diana Bolotin to Technology, Pharmaceutical
This is a "connection" page, showing publications Diana Bolotin has written about Technology, Pharmaceutical.
Connection Strength
0.025
-
Safety of a novel microneedle device applied to facial skin: a subject- and rater-blinded, sham-controlled, randomized trial. Arch Dermatol. 2012 Jun; 148(6):711-7.
Score: 0.025